WINTHER trial aims to offer improved cancer care

The WINTHER trial was heralded at the WIN (Worldwide Networking in personalised medicine) Symposium as a new generation personalized medicine study that aims to provide biology-oriented therapy to patients with advanced solid tumors. The Symposium was held in Paris from the 10th to 12th of July, 2013 and was sponsored by the WIN Consortium, which also planned this hallmark trial around the ambitious goal of extending personalised approaches to the 60 to 70% of patients with advanced malignancies whose tumours do not express drugable targets. Read more here.